Literature DB >> 2566352

Characterization of pigment aggregating alpha 2-adrenoceptors of fish melanophores by use of different agonists after partial irreversible receptor inactivation.

J O Karlsson1, R G Andersson, N Grundström.   

Abstract

1. The affinity for, and the intrinsic efficacy on, postsynaptic melanosome aggregating alpha 2-adrenoceptors of fish melanophores was studied for B-HT 920, clonidine, medetomidine, noradrenaline, phenylephrine and UK-14,304. Investigations were carried out by evaluating the effects of progressive, irreversible inactivation of the alpha 2-adrenoceptors by benextramine. 2. The double reciprocal plots of equieffective concentrations of B-HT 920, clonidine, noradrenaline and phenylephrine were linear, which indicated that these compounds exerted their effects, mainly, through interaction with one receptor site. 3. The affinity for the alpha 2-adrenoceptor selective agonist B-HT 920, was found to be about 1000 times higher than the affinity for the alpha 1-adrenoceptor selective agonist phenylephrine. 4. The corresponding plot of equieffective concentrations of medetomidine was not linear, which may indicate that this imidazole compound exerted its effect through more than one receptor site. However, when phenoxybenzamine was used in place of the more selective benextramine, a linear relationship was obtained.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2566352      PMCID: PMC1854472          DOI: 10.1111/j.1476-5381.1989.tb11945.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

1.  Lack of cross-desensitization between structurally dissimilar alpha-adrenoceptor agonists.

Authors:  R R Ruffolo; B S Turowski; P N Patil
Journal:  J Pharm Pharmacol       Date:  1977-06       Impact factor: 3.765

2.  A functional basis for classification of alpha-adrenergic receptors.

Authors:  S Berthelsen; W A Pettinger
Journal:  Life Sci       Date:  1977-09-01       Impact factor: 5.037

3.  Pharmacological classification of adrenergic alpha receptors in the guinea pig.

Authors:  J E Wikberg
Journal:  Nature       Date:  1978-05-11       Impact factor: 49.962

4.  Relative pre- and postsynaptic potencies of alpha-adrenoceptor agonists in the rabbit pulmonary artery.

Authors:  K Starke; T Endo; H D Taube
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

Review 5.  Presynaptic regulation of catecholamine release.

Authors:  S Z Langer
Journal:  Biochem Pharmacol       Date:  1974-07-01       Impact factor: 5.858

6.  Adrenergic innervation and drug responses of the oval sphincter in the swimbladder of the cod (Gadus morhua).

Authors:  S Nilsson
Journal:  Acta Physiol Scand       Date:  1971-12

7.  Pre-junctional alpha 2-adrenoceptor activity of B-HT920.

Authors:  D R Mottram
Journal:  J Pharm Pharmacol       Date:  1983-10       Impact factor: 3.765

8.  Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists.

Authors:  R B Parker; D R Waud
Journal:  J Pharmacol Exp Ther       Date:  1971-04       Impact factor: 4.030

9.  Review important concepts of receptor theory.

Authors:  R R Ruffolo
Journal:  J Auton Pharmacol       Date:  1982-12

10.  Pharmacological evidence for high affinity and low affinity a2-adrenoceptor binding sites in rat vas deferens.

Authors:  D R Mottram
Journal:  Arch Int Pharmacodyn Ther       Date:  1983-07
View more
  2 in total

1.  Azi-medetomidine: Synthesis and Characterization of a Novel α2 Adrenergic Photoaffinity Ligand.

Authors:  Andrew R McKinstry-Wu; Kellie A Woll; Thomas T Joseph; Weiming Bu; E Railey White; Natarajan V Bhanu; Benjamin A Garcia; Grace Brannigan; William P Dailey; Roderic G Eckenhoff
Journal:  ACS Chem Neurosci       Date:  2019-11-05       Impact factor: 4.418

2.  Cloning and expression of a fish alpha 2-adrenoceptor.

Authors:  S P Svensson; T J Bailey; D J Pepperl; N Grundström; S Ala-Uotila; M Scheinin; J O Karlsson; J W Regan
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.